Physician profile
James Macfoy
NPI 1356711253
$3,672.00
in general payments reported to CMS, 2019-2025
21 companies · $546 in 2025
The $546 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2022: $1,557 · 2023: $829 · 2024: $618 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,928 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,928.33 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $956.65 | 2022-2024 | Venclose Maven Catheter |
| Novartis Pharmaceuticals Corporation | $718.31 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $285.18 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals Lp | $247.20 | 2022-2025 | Farxiga, Atacand |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $238.37 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $232.70 | 2021-2025 | Varithena Administration Pack, Synergy |
| Janssen Pharmaceuticals, INC | $209.15 | 2022-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $176.43 | 2021-2025 | Jardiance |
| Kiniksa Pharmaceuticals, Ltd. | $109.99 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $94.70 | 2022-2025 | |
| Cvrx, INC. | $55.23 | 2022 | |
| Amgen INC. | $53.35 | 2023-2025 | Repatha |
| Abiomed | $47.05 | 2024-2025 | Impella |
| Imperative Care, INC | $46.10 | 2025 | Symphony Catheter |
| Inari Medical, INC. | $43.19 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $38.90 | 2021-2024 | |
| Medtronic, INC. | $38.55 | 2022 | |
| Becton, Dickinson and Company | $33.16 | 2023-2024 | Venclose Maven Catheter |
| Pfizer INC. | $16.69 | 2025 | |
| Glaxosmithkline, LLC. | $16.52 | 2025 | Shingrix, Arexvy |
| E.R. Squibb & Sons, L.L.C. | $14.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Macfoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.